2008 ICD-9 Coding Changes

Size: px
Start display at page:

Download "2008 ICD-9 Coding Changes"

Transcription

1 Coding Update: New, Revised and Deleted Codes Effective October 1, 2007 Presented By: Melinda A. Gaboury, CEO Healthcare Provider Solutions, Inc ICD-9 Coding Changes The 2008 ICD-9 codes will be effective October 1, 2007 There is no grace period for the use of these codes This is for episodes that begin on or after the October 1, 2007 date 2008 ICD-9 Codes There are 142 New ICD-9 codes There are 17 Invalid ICD-9 codes There are 5 Revised ICD-9 Codes There are 2 New and 1 Invalid ICD-9 codes which were not included in the proposed rule, but WILL be effective on October 1,

2 2008 New ICD-9 Codes Of the NEW ICD-9 codes, 54 of them are for some type of Lymphoma They are found in the 200 ICD-9 category They are divided by cell type and location They will be 5 digit ICD-9 codes 2008 New ICD-9 Codes Marginal zone lymphoma Mantle cell lymphoma Primary central nervous system lymphoma Anaplastic large cell lymphoma Large cell lymphoma Peripheral T-cell lymphoma (Note: On New ICD-9 listing T-Cell is listed with repeated number of ) 2008 New ICD-9 Codes Unspecified Site, Extranodal and Solid Organ Sites 200.X0 Lymph nodes of head, face and neck 200.X1 Intrathoracic lymph nodes 200.X2 Intraabdominal lymph nodes 200.X3 Lymph nodes of axilla and upper limb 200.X4 Lymph nodes of inguinal region and lower limb 200.X5 Intrapelvic Lymph nodes 200.X6 Spleen 200.X7 Lymph nodes of multiple sites 200.X8 2

3 2008 New ICD-9 Codes Three additional Cancer ICD-9 codes: Carcinoma in situ, unspecified female genital organ Carcinoma in situ, vagina Carcinoma in situ, vulva 2008 New ICD-9 Codes Additional endocrine related ICD-9 codes: Glucocorticoid deficiency Mineralocorticoid deficiency Multiple endocrine neoplasia [MEN] type I Multiple endocrine neoplasia [MEN] type IIA Multiple endocrine neoplasia [MEN] type IIB 2008 New ICD-9 Codes New Blood Related ICD-9 codes: Red cell aplasia (acquired) (adult) (with thymoma) Other specified aplastic anemias Bandemia 3

4 2008 New ICD-9 Codes New Muscular and Neurological Related ICD-9 codes: Myotonic muscular dystrophy Myotonic chondrodystrophy Drug induced myotonia Other specified myotonic disorder 2008 New ICD-9 Codes New Cardiac and Pulmonary Related ICD-9 codes: Chronic total occlusion of coronary artery Septic pulmonary embolism Cardiac tamponade Chronic total occlusion of artery of the extremities 449 Septic arterial embolism 488 Influenza due to identified avian influenza virus 2008 New ICD-9 Codes Two ICD-9 codes which were not finalized in time for the proposed rule, but will be effective October 1, 2007: Infection due to central venous catheter Infection following other infusion, injection, transfusion, or vaccination 4

5 2008 New ICD-9 Codes ICD-9 codes which could affect speech-language pathology include: Speech and language development due to hearing loss Acquired auditory processing disorder Conductive hearing loss, unilateral Conductive hearing loss, bilateral Neural hearing loss, unilateral Sensory hearing loss, unilateral Mixed hearing loss, unspecified Mixed hearing loss, unilateral Mixed hearing loss, bilateral 2008 New ICD-9 Codes ICD-9 codes which could affect speechlanguage pathology include the new specific Dysphagia category: Dysphagia, unspecified Dysphagia, oral phase Dysphagia, oropharyngeal phase Dysphagia, pharyngeal phase Dysphagia, pharyngoesophageal phase Other dysphagia 2008 New ICD-9 Codes Additional New ICD-9 codes include various other issues including: Dental issues Female genitalia Childhood development issues Ascites Anal sphincter 5

6 2008 New ICD-9 Codes New V-Codes include several history codes for both personal and family histories Disability examination Dual sensory impairment Procreative management and fertility Genetic susceptibility Special Screenings 2008 Invalid ICD-9 Codes Carcinoma in situ, other and unspecified female genital organs Corticoadrenal insufficiency Polyglandular activity in multiple endocrine adenomatosis Other specified aplastic anemias Myotonic Disorders Other disorders of iris and ciliary body Mixed conductive and sensourinal hearing loss Dystrophy of vulva Dysphagia Ascites Complications of medical care, not elsewhere classified, Other infection 2008 Invalid ICD-9 Codes V17.4 Family history of other cardiovascular diseases V18.1 Family history of other endocrine and metabolic diseases V26.4 Procreative management, general counseling and advice V26.8 Other specified procreative management V68.0 Issue of medical certificates V84.8 Genetic susceptibility to other disease These codes are all invalid due to the fact that they have either been expanded on, a new category has been created, or they have been incorporated elsewhere 6

7 2008 Revised ICD-9 Codes Botulism food poisoning Periodic paralysis Central hearing loss Sensorineural hearing loss, bilateral Deaf, nonspeaking, not elsewhere classified These codes are all revised due to the fact that either new categories were created or the ICD-9 code was expanded to become more specific ICD-9 Codes To obtain a copy of these changes, link to: agnosticcodes/07_summarytables.asp #TopOfPage OASIS Coding When V-Code is used at M0230 where a Case Mix Diagnosis is currently being used you will need to put Case Mix Diagnosis in M M0246 in 2008 Use of M0245/M0246 is OPTIONAL!! 7

8 New OASIS Item: M0245 OASIS Coding This item allows the use of V-codes in the diagnosis code M0 items M0230 & M0240 The only time there will be a code in M0245a and M0245b is when the V code in M0230 replaces a 2-part manifestation code M0246 (use in 2008) This item allows the use of V-codes in the diagnosis code M0 items M0230 & M0240 opportunity to report code that V-code replaced on each line OASIS Coding (M0230) Primary Diagnosis & (M0240) Other Diagnoses (M0246) Case Mix Diagnoses (OPTIONAL) (1) (2) (3) (4) Complete only if the V code in Colum n 2 is reported in Complete only if a V code in place of a case mix ICD-9-CM and severity Column 2 is reported in diagnosis that is a multiple rating for each condition place of a case mix coding situation (e.g., a diagnosis. manifestation code). ICD-9-CM / Description/ Description/ Description Severity Rating ICD-9-CM ICD-9-CM (M0230) Primary Diagnosis (V codes are allowed) (V or E codes NOT allowed) (V or E codes NOT allowed) a. ( ) a. a ( ) ( ) (M0240) Other Diagnoses (V or E codes are allowed) (V or E codes NOT allowed) (V or E codes NOT allowed) b. ( ) b. b ( ) ( ) c. ( ) c. c ( ) ( ) d. ( ) d. d ( ) ( ) e. ( ) e. e ( ) ( ) f. ( ) f. f ( ) ( ) General Coding Principles Coding for Home Health May or may not relate to recent hospital stay Must relate to services rendered by the HHA If more than one diagnosis is being treated concurrently the one that represents the most acute condition & requires most intensive services is the one that should be entered 8

9 General Coding Principles Include not only conditions that are actively addressed in the POC, but also comorbidities affecting the patient s responsiveness to treatment Avoid listing diagnoses that are of mere historical interest & without impact on patient progress or outcome Expanded Diagnosis Categories Stroke * Neurological brain & peripheral * Multiple Sclerosis * Hypertension Gait disorders * Heart disease Blindness Diabetes Skin Dysphagia* Gastrointestinal Pulmonary Cancer Orthopedic * Blood disorders Psychoses & affective disorders *codes that require additional criteria 9

10 Thank You For Listening! Please fill out evaluation forms! Healthcare Provider Solutions, Inc Kermit Drive, Suite 513 Nashville, TN

11 49782 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.000</GPH>

12 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.001</GPH>

13 49784 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.002</GPH>

14 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.003</GPH>

15 49786 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.004</GPH>

16 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.005</GPH>

17 49788 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.006</GPH>

18 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.007</GPH>

19 49790 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.008</GPH>

20 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.009</GPH>

21 49792 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.010</GPH>

22 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.011</GPH>

23 49794 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.012</GPH>

24 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.013</GPH>

25 49796 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.014</GPH>

26 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.015</GPH>

27 49798 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.016</GPH>

28 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.017</GPH>

29 49800 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.018</GPH>

30 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.019</GPH>

31 49802 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.020</GPH>

32 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.021</GPH>

33 49804 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.022</GPH>

34 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.023</GPH>

35 49806 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.024</GPH>

36 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.025</GPH>

37 49808 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.026</GPH>

38 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.027</GPH>

39 49810 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.028</GPH>

40 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.029</GPH>

41 49812 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.030</GPH>

42 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.031</GPH>

43 49814 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.032</GPH>

44 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.033</GPH>

45 49816 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.034</GPH>

46 Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Rules and Regulations VerDate Aug<31> :35 Aug 28, 2007 Jkt PO Frm Fmt 4701 Sfmt 4725 E:\FR\FM\29AUR2.SGM 29AUR2 ER29AU07.035</GPH>

Infant botulism Wound botulism

Infant botulism Wound botulism Table 6A - New Diagnosis Codes Effective October 1, 2007 Note: The final addendum providing complete information on changes to the diagnosis part of ICD-9-CM is posted on CDC s webpage at: www.cdc.gov/nchs/icd9.htm.

More information

December 1, 2006 VIA ELECTRONIC MAIL

December 1, 2006 VIA ELECTRONIC MAIL VIA ELECTRONIC MAIL, MPH, RHIA Medical Classification Administrator National Center for Health Statistics 3311 Toledo Road Room 2402 Hyattsville, Maryland 20782 Dear Donna: The American Health Information

More information

I will first address those proposals that have been recommended for implementation in October 2006:

I will first address those proposals that have been recommended for implementation in October 2006: VIA ELECTRONIC MAIL, MPH, RHIA Medical Classification Administrator National Center for Health Statistics 3311 Toledo Road Room 2402 Hyattsville, Maryland 20782 Dear Donna: The American Health Information

More information

50198 Federal Register / Vol. 75, No. 157 / Monday, August 16, 2010 / Rules and Regulations

50198 Federal Register / Vol. 75, No. 157 / Monday, August 16, 2010 / Rules and Regulations 50198 Federal Register / Vol. 75, No. 157 / Monday, August 16, 2010 / Rules and Regulations mstockstill on DSKH9S0YB1PROD with RULES2 VerDate Mar2010 17:02 Aug 13, 2010 Jkt 220001 PO 00000 Frm 00158

More information

Financial & Management Aspects of OASIS C2

Financial & Management Aspects of OASIS C2 Financial & Management Aspects of OASIS C2 Presented By: Melinda A. Gaboury, COS C Healthcare Provider Solutions, Inc. 615 399 7499 info@healthcareprovidersolutions.com WHAT DOES OASIS C2 IMPACT? HHRG/HIPPS

More information

SAMPLE. Laboratory Services. An essential coding, billing, and reimbursement resource for laboratory and pathology services ICD-10

SAMPLE. Laboratory Services. An essential coding, billing, and reimbursement resource for laboratory and pathology services ICD-10 Coding and Payment Guide www.optumcoding.com Laboratory Services An essential coding, billing, and reimbursement resource for laboratory and pathology services 2017 ICD-10 A full suite of resources including

More information

WASHINGTON perspectives

WASHINGTON perspectives An Analysis and Commentary on Federal Health Care Issues by Larry Goldberg CMS Announces Final Inpatient Psychiatric Facilities PPS Update for FY 2017 The Centers for Medicare and Medicaid Services (CMS)

More information

Yescarta (axicabtagene ciloleucel)

Yescarta (axicabtagene ciloleucel) Last Review Date: March 30, 2018 Effective Date: April 1, 2018 Number: MG.MM.PH.42 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Adcetris (Brentuximab Vedotin) MP-035-MD-WV Provider Notice Date: 07/03/2017 Original Effective Date: 08/03/2017 Annual Approval Date:

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Adcetris (brentuximab vedotin) MP-035-MD-DE Provider Notice Date: 08/01/2017 Original Effective Date: 09/01/2017 Annual Approval Date:

More information

Neoplasms/Lymphoma/Leukemia

Neoplasms/Lymphoma/Leukemia Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and

More information

Fiscal Year 2008 ICD-9-CM Update

Fiscal Year 2008 ICD-9-CM Update Fiscal Year 2008 ICD-9-CM Update Audio Seminar/Webinar September 18, and September 20, 2007 Practical Tools for Seminar Learning Copyright 2007 American Health Information Management Association. All rights

More information

Chapter 1: Certain Infectious and parasitic diseases (A00-B99)

Chapter 1: Certain Infectious and parasitic diseases (A00-B99) ICD-10-CM Part 5 Chapter 1: Certain Infectious and parasitic diseases (A00-B99) New sub-chapter: Infections with a predominantly sexual mode of transmission (A50-A64) You will not find: septicemia - rather,

More information

Subject: Belinostat (Beleodaq ) Injection

Subject: Belinostat (Beleodaq ) Injection 09-J2000-21 Original Effective Date: 11/15/14 Reviewed: 01/09/19 Revised: 02/15/19 Subject: Belinostat (Beleodaq ) Injection THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

CPT Codes: The following ICD-10-CM codes support the medical necessity of CPT code 82306:

CPT Codes: The following ICD-10-CM codes support the medical necessity of CPT code 82306: CPT s: 82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 82652 Vitamin D; 1, 25 dihydroxy, includes fraction(s), if performed The following ICD-10-CM codes support the medical necessity of

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY CLINICAL MEDICAL POLICY Policy Name: Rituxan (rituximab) Policy Number: MP-031-MD-DE Responsible Department(s): Medical Management; Clinical Pharmacy Provider Notice Date: 10/01/2017 Issue Date: 11/01/2017

More information

Home Health Prospective Payment System. Overview

Home Health Prospective Payment System. Overview Overview Version 6117 January 2017 PBL-046 Java is a registered trademark of Oracle and/or its affiliates. Table of Contents Overview of the... 5 Background and versioning... 5 Changes for this version...

More information

Vitamin D Assay Testing For services performed on or after

Vitamin D Assay Testing For services performed on or after 2018 MEDICARE LOCAL COVERAGE DETERMINATION (LCD) - L36692 CPT CODES: 82306, 82652 Vitamin D Assay Testing For services performed on or after 2-3-2017 DLS TEST CODE AND NAME 49907 (1,25 DIHYDROXY) (CPT

More information

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICAL POLICY ADCETRIS (Brentuximab Vedotin) MP-035-MD-DE Provider Notice Date: 11/1/2016 Original Effective Date: 12/1/2016 Medical Management Annual

More information

Non-covered ICD-10-CM Codes for All Lab NCDs

Non-covered ICD-10-CM Codes for All Lab NCDs Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,

More information

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable

More information

Rituxan Hycela (rituximab and hyaluronidase human) (Subcutaneous)

Rituxan Hycela (rituximab and hyaluronidase human) (Subcutaneous) Rituxan Hycela (rituximab and hyaluronidase human) (Subcutaneous) Document Number: IC-0322 Last Review Date: 02/06/2018 Date of Origin: 7/20/2010 Dates Reviewed: 09/2010, 12/2010, 02/2011, 03/2011, 05/2011,

More information

Reimbursement Guide. Hospital Outpatient. Please see Important Safety Information on page 2 and click here for full Prescribing Information.

Reimbursement Guide. Hospital Outpatient. Please see Important Safety Information on page 2 and click here for full Prescribing Information. Reimbursement Guide Hospital Outpatient Information provided in this resource is for informational purposes only and does not guarantee that codes will be appropriate or that coverage and reimbursement

More information

TABLE 6A. - NEW DIAGNOSIS CODES

TABLE 6A. - NEW DIAGNOSIS CODES Diagnosis Description CC MDC MS-DRG 209.31 Merkel cell carcinoma of the face N 09 595,596 209.32 Merkel cell carcinoma of the scalp and neck N 09 595,596 209.33 Merkel cell carcinoma of the upper limb

More information

American Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights

American Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights American Board of Physical Medicine & Rehabilitation Part I Curriculum & Weights Neurologic Disorders 30% Stroke Spinal Cord Injury Traumatic Brain Injury Neuropathies a) Mononeuropathies b) Polyneuropathies

More information

Non-covered ICD-10-CM Codes for All Lab NCDs

Non-covered ICD-10-CM Codes for All Lab NCDs Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,

More information

Reimbursement Guide. Hospital Outpatient. Please see Important Safety Information on page 2 and click here for full Prescribing Information.

Reimbursement Guide. Hospital Outpatient. Please see Important Safety Information on page 2 and click here for full Prescribing Information. Reimbursement Guide Hospital Outpatient Information provided in this resource is for informational purposes only and does not guarantee that codes will be appropriate or that coverage and reimbursement

More information

Covered Critical Illness Conditions Appendix

Covered Critical Illness Conditions Appendix Covered Critical Illness Conditions Appendix Effective Date: February 1, 2010 This Appendix contains definitions for those Conditions that are covered under the Manulife Financial Group Critical Illness

More information

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable

More information

Documentation for the IRF Provider

Documentation for the IRF Provider Documentation for the IRF Provider Timothy N. Brundage, MD, CCDS Certified Clinical Documentation Specialist DrBrundage@gmail.com 1 Medicare controls the ball field If you want to play ball, you have to

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals

More information

H. R. ll. To provide for the rescheduling of marijuana and for the medical use of marijuana in accordance with the laws of the various States.

H. R. ll. To provide for the rescheduling of marijuana and for the medical use of marijuana in accordance with the laws of the various States. F:\M\BLUMEN\BLUMEN_0.XML [ H] TH CONGRESS ST SESSION... (Original Signature of Member) H. R. ll To provide for the rescheduling of marijuana and for the medical use of marijuana in accordance with the

More information

ICD-10-CM - Session 2. Cardiovascular Conditions, Neoplasms and Diabetes

ICD-10-CM - Session 2. Cardiovascular Conditions, Neoplasms and Diabetes ICD-10-CM - Session 2 Cardiovascular Conditions, Neoplasms and Diabetes Agenda General coding guidelines Acute myocardial infarction Hypertension Cerebrovascular accidents and sequelae Neoplasm and history

More information

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant

More information

Using 3-Digit ICD-9-CM Codes with the Elixhauser Comorbidity Index

Using 3-Digit ICD-9-CM Codes with the Elixhauser Comorbidity Index Congestive Heart Failure 398.91 Rheumatic heart failure (congestive) 398 Other rheumatic heart disease 402.01, 402.11, 402.91 402 Hypertensive heart disease 404.01, 404.03, 404.11, 404.13, 404.91, 404.93

More information

Report of Children with Disabilities (IDEA) Ages 6 through 21 by Disability, Educational Environment, and Age Group (OSEP010)

Report of Children with Disabilities (IDEA) Ages 6 through 21 by Disability, Educational Environment, and Age Group (OSEP010) Disability Category class 80% or more of the class 40% through 79% of class less than 40% of 6-11 12-17 18-21 6-11 12-17 18-21 6-11 12-17 18-21 Intellectual disability 818 1,624 462 1,005 1,830 483 3,036

More information

Our Specified Illness Benefit Is Now Even Better.

Our Specified Illness Benefit Is Now Even Better. Our Specified Illness Benefit Is Now Even Better. Now Covering 47 Specified Illnesses 20 Partial Payment Illnesses Enhancements to our Specified Illness Benefit We have made enhancements to our Specified

More information

List of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019

List of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019 List of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019 Table of Contents Table 4: Hospitalization Summary for Medicare Dialysis Patients... 4 SEPTICEMIA 4 MYOCARDIAL

More information

Department of Health and Human Services

Department of Health and Human Services Friday, August 24, 2007 Part III Department of Health and Human Services Food and Drug Administration 2 CFR Parts 606 and 60 Current Good Manufacturing Practice for Blood and Blood Components; Notification

More information

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization

More information

Top 10 ICD-10 Coding Errors (and how to fix them!) Presented by Jennifer Warfield, BSN, HCS-D, COS-C Education Director, PPS Plus

Top 10 ICD-10 Coding Errors (and how to fix them!) Presented by Jennifer Warfield, BSN, HCS-D, COS-C Education Director, PPS Plus (and how to fix them!) Presented by Jennifer Warfield, BSN, HCS-D, COS-C Education Director, PPS Plus Top 10 ICD-10 Coding Errors (and how to fix them!) Top 10 Primary Diagnoses In ICD-10 ICD-10 Codes

More information

Episodes of Care Risk Adjustment

Episodes of Care Risk Adjustment Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous

More information

Summary of September 2006 ICD-9-CM Coordination and Maintenance Committee Meeting

Summary of September 2006 ICD-9-CM Coordination and Maintenance Committee Meeting Summary of September 2006 ICD-9-CM Coordination and Maintenance Committee Meeting The ICD-9-CM Coordination and Maintenance Committee, cosponsored by the National Center for Health Statistics (NCHS) and

More information

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF

More information

S2 File. Clinical Classifications Software (CCS). The CCS is a

S2 File. Clinical Classifications Software (CCS). The CCS is a S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous

More information

Velcade (bortezomib) Document Number: IC-0137

Velcade (bortezomib) Document Number: IC-0137 Velcade (bortezomib) Document Number: IC-0137 Last Review Date: 11/21/2017 Date of Origin: 11/28/2011 Dates Reviewed: 12/2011, 03/2012, 06/2012, 09/2012, 12/2012, 03/2013, 06/2013, 09/2013, 12/2013, 03/2014,

More information

ICD-10-CM Coding and Documentation for Long Term Care

ICD-10-CM Coding and Documentation for Long Term Care ICD-10-CM Coding and Documentation for Long Term Care June 3, 2014 Chris Hoskins, MA, RHIA, CTR, CHC Karen Fabrizio, RHIA CHTS-CP AHIMA Approved ICD-10-CM/PCS Trainers Objectives Review 2014 Coding Guidelines

More information

INGENIX Ingenix

INGENIX Ingenix New, Revised, and Invalid ICD-9-CM Codes for Fiscal 2012 The following code lists contain the new, revised, and invalid ICD-9-CM codes effective October 1, 2011, as approved by the ICD-9-CM Coordination

More information

APPENDIX I. Free-Standing Radiation Therapy Centers Cancer Case Identification Program

APPENDIX I. Free-Standing Radiation Therapy Centers Cancer Case Identification Program APPENDIX I Free-Standing Radiation Therapy Centers Cancer Case Identification Program I-1 Sending Radiation Therapy data to FCDS Beginning January 1, 2003, all Florida Radiation Therapy Centers must send

More information

2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors

2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors 2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors ICD-10 Code Explanation of Code Malignant neoplasms (excluding

More information

Summary of the Home Health Prospective Payment System Final Rule FY 2014

Summary of the Home Health Prospective Payment System Final Rule FY 2014 Summary of the Home Health Prospective Payment System Final Rule FY 2014 Medicare and Medicaid Programs; Home Health Prospective Payment System Rate Update for CY 2014, Home Health Quality Reporting Requirements,

More information

ICD-10 Physician Education. General Surgery

ICD-10 Physician Education. General Surgery ICD-10 Physician Education General Surgery 1 Training Objectives ICD-9 to ICD-10 Comparison Documentation Tips Additional Educational Opportunities Questions 2 ICD-9 to ICD-10 Comparison Code Structure

More information

Chapter 2 Neoplasms C00-D49 November 11, Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p.

Chapter 2 Neoplasms C00-D49 November 11, Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p. Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p. 22 1 C00 C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, hematopoietic

More information

figures facts & managedcareoncology.com Estimated New Cases and Deaths for Lymphoma by Sex, U.S., 2010

figures facts & managedcareoncology.com Estimated New Cases and Deaths for Lymphoma by Sex, U.S., 2010 facts & figures In every issue, Facts & Figures provides snapshots of information key to managed care oncology professionals. This installment features data regarding lymphoma. We continue to include topical

More information

Additional Required Medical Evidence Checklist

Additional Required Medical Evidence Checklist Additional Required Medical Evidence Checklist Types Of Claims Documents Required Accident Indemnity Rider (AIR / AIS / CPAB / CAB) Death Claim 1. Accident Claim Form 2. Medical report (only for claim

More information

Cheryl Ericson, MS, RN, CCDS, CDIP, AHIMA Approved ICD 10 CM/PCS Trainer Clinical Documentation Program Manager for ezdi.

Cheryl Ericson, MS, RN, CCDS, CDIP, AHIMA Approved ICD 10 CM/PCS Trainer Clinical Documentation Program Manager for ezdi. A Venture of Cheryl Ericson, MS, RN, CCDS, CDIP, AHIMA Approved ICD 10 CM/PCS Trainer Clinical Documentation Program Manager for ezdi HIPAA Code Sets HIPAA legislation required use of the International

More information

Student Outline. Improving Transportation Safety: Commercial Driver Medical Examiner Training CHAPTER 1. General FMCSA Information

Student Outline. Improving Transportation Safety: Commercial Driver Medical Examiner Training CHAPTER 1. General FMCSA Information Student Outline CHAPTER 1 General FMCSA Information FMCSA Mission Statement / Dedicated to Safety / NRCME Important Definitions Regulations Vs. Medical Guidelines Privacy and the Medical Examination 13

More information

Effective October 1, 2016

Effective October 1, 2016 2017 Pediatric ICD-10-CM Codes Effective October 1, 2016 There are 1,943 new codes and 422 code revisions to ICD-10-CM for 2017. Listed below are the new codes and revisions we believe are of most interest

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

H. RES. 739 IN THE HOUSE OF REPRESENTATIVES

H. RES. 739 IN THE HOUSE OF REPRESENTATIVES IV 0TH CONGRESS D SESSION H. RES. Expressing the sense of the House of Representatives that the President should declare lung cancer a public health priority and should implement a comprehensive inter-agency

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

Khapzory (levoleucovorin) (Intravenous)

Khapzory (levoleucovorin) (Intravenous) Khapzory (levoleucovorin) (Intravenous) Last Review Date: 12/04/2018 Date of Origin: 12/04/2018 Dates Reviewed: 12/2018 Document Number: IC-0408 I. Length of Authorization Coverage will be provided for

More information

California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar

California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar Production Automation and Quality Control Unit Data Alert - Registrar 2015-061 REVISED Casefinding List FY2016 Please see additions and revisions noted below in red text. ICD-10-CM Codes have been adopted

More information

COVER WHERE IT MATTERS. Our 17 ABI+ definitions explained. Protection For advisers only

COVER WHERE IT MATTERS. Our 17 ABI+ definitions explained. Protection For advisers only Protection For advisers only COVER WHERE IT MATTERS Our 17 ABI+ definitions explained WE RE ALWAYS LOOKING AT WAYS TO IMPROVE THE COVER WE OFFER. 87%* of critical illness claims paid in 2017 were for cancer,

More information

Possible Precautions or Contraindications. Physical/Sexual/Emotional Abuse. Exacerbations of medical conditions

Possible Precautions or Contraindications. Physical/Sexual/Emotional Abuse. Exacerbations of medical conditions Dear Physician, Your patient,, DOB: is interested in participating in one of the following: Physical and/or Occupational Therapy evaluation and treatment using all appropriate treatment methods including

More information

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15 1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1

More information

Premium Specialty: Pediatrics

Premium Specialty: Pediatrics Premium Specialty: Pediatrics Credentialed Specialties include: Adolescent Medicine, Pediatric Adolescent, and Pediatrics This document is designed to be used in conjunction with the UnitedHealth Premium

More information

Non-covered ICD-10-CM Codes for All Lab NCDs

Non-covered ICD-10-CM Codes for All Lab NCDs Non-covered ICD-10-CM Codes for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the

More information

In your own words, please write the reason you are here. Please be specific, putting in dates as necessary. Use the back of the form if needed.

In your own words, please write the reason you are here. Please be specific, putting in dates as necessary. Use the back of the form if needed. Name: SS# In your own words, please write the reason you are here. Please be specific, putting in dates as necessary. Use the back of the form if needed. Patient Medical, Surgical and Family History Review

More information

Fusilev (levoleucovorin) Document Number: IC-0183

Fusilev (levoleucovorin) Document Number: IC-0183 Fusilev (levoleucovorin) Document Number: IC-0183 Last Review Date: 2/1/2018 Date of Origin: 01/02/2014 Dates Reviewed: 08/2014, 03/2015, 05/2015, 08/2015, 11/2015, 02/2016, 05/2016, 08/2016, 11/2016,

More information

ICD-9-CM Home Health Coding Impact on Reimbursement

ICD-9-CM Home Health Coding Impact on Reimbursement ICD-9-CM Home Health Coding Impact on Reimbursement Presented by HealthCare ConsultLink Linda Parker, RN, BSN, COS-C, HCS-D Objectives Identify principles for determining primary/secondary diagnoses Identify

More information

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC A. LCD ID Number: L35032 Status: A-Approved

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC A. LCD ID Number: L35032 Status: A-Approved LCD for Flow Cytometry (L35032) Contractor Name: Novitas Solutions, Inc. Contractor Number: 12501 Contractor Type: MAC A LCD ID Number: L35032 Status: A-Approved Contractor Information LCD Information

More information

Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews

Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews Chapter 10 Respiratory System J00-J99 Presented by: Jesicca Andrews 1 Respiratory System 2 Respiratory Infections A respiratory infection cannot be assumed from a laboratory report alone; physician concurrence

More information

TOTAL HIP AND KNEE REPLACEMENTS. FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES

TOTAL HIP AND KNEE REPLACEMENTS. FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES TOTAL HIP AND KNEE REPLACEMENTS FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES The Pennsylvania Health Care Cost Containment Council April 2005 Preface This document serves as

More information

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card 2014: Reference Mapping Card 162.3 Malignant neoplasm upper lobe lung 162.5 Malignant neoplasm lower lobe lung 162.9 lung/bronchus 396.2 396.3 Mitral insufficiency, aortic stenosis Mitral aortic valve

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable

More information

Men s Health Coding & Payment Quick Reference

Men s Health Coding & Payment Quick Reference Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding or site of service requirements. The coding options listed within this guide are commonly used codes

More information

MDGuidelines API: Case Fit v3 Specification 1.3

MDGuidelines API: Case Fit v3 Specification 1.3 MDGuidelines API: Case Fit v3 Specification 1.3 Date: August 23, 2017 1 Overview 1.1 Purpose and Intended Audience The purpose of this document is to provide detailed descriptions and specifications for

More information

DISORDERS OF MALE GENITALS

DISORDERS OF MALE GENITALS Wit JM, Ranke MB, Kelnar CJH (eds): ESPE classification of paediatric endocrine diagnosis. 9. Testicular disorders/disorders of male genitals. Horm Res 2007;68(suppl 2):63 66 ESPE Code Diagnosis OMIM ICD10

More information

Definitions. Peace of mind today and tomorrow. CRITICAL ILLNESS Basic benefit Deluxe benefit. CRITICAL ILLNESS MULTI-PROTECTION (per child)

Definitions. Peace of mind today and tomorrow. CRITICAL ILLNESS Basic benefit Deluxe benefit. CRITICAL ILLNESS MULTI-PROTECTION (per child) Definitions Peace of mind today and tomorrow CRITICAL ILLNESS Basic benefit Deluxe benefit CRITICAL ILLNESS MULTI-PROTECTION (per child) Here are the definitions of the critical and non-critical illnesses

More information

2014 NATIONAL COVERAGE DETERMINATION (NCD) CPT CODE(S): 84436, 84439, 84443, THYROID TESTING DESCRIPTION

2014 NATIONAL COVERAGE DETERMINATION (NCD) CPT CODE(S): 84436, 84439, 84443, THYROID TESTING DESCRIPTION 017.50-017.56 Tuberculosis of the thyroid gland 183.0 Malignant neoplasm of ovary 193 Malignant neoplasm of thyroid gland 194.8 Malignant neoplasm of other endocrine glands and related structures 198.89

More information

MEDICAL DEFINITIONS REFERENCE GUIDE

MEDICAL DEFINITIONS REFERENCE GUIDE MEDICAL DEFINITIONS REFERENCE GUIDE Preparation Date: 17 September 2017 This reference guide provides detail of medical definitions that have been reviewed and updated for claimable events occurring on

More information

January Intravenous Nurse Day ALL MONTH LONG SUN MON TUE WED THU FRI SAT. Blood Donor Month. Glaucoma Awareness Month

January Intravenous Nurse Day ALL MONTH LONG SUN MON TUE WED THU FRI SAT. Blood Donor Month. Glaucoma Awareness Month January 1 2 3 4 5 6 Blood Donor Month 7 8 9 10 11 12 13 Glaucoma Awareness Month Volunteer Blood Donor Month Cervical Health Awareness Month 14 15 16 17 18 19 20 Thyroid Awareness Month Birth Defects Prevention

More information

NEW YORK - ENTIRE STATE - MAC - PART A - NGS LABORATORY - TABLE OF CONTENTS

NEW YORK - ENTIRE STATE - MAC - PART A - NGS LABORATORY - TABLE OF CONTENTS LABORATORY - TABLE OF CONTENTS CPT to LCD ID CodeMap Mappings... 2 -Erythrocyte Sedimentation Rate (ESR)... 4 L25650-Homocysteine Level, Serum... 20 L25879-Acid Phosphatase... 31 L26375-B-type Natriuretic

More information

APR-DRG Description Ave Charge

APR-DRG Description Ave Charge Abdominal Pain 16,500.25 2.8 6,000.09 Acute & Subacute Endocarditis 15,339.30 3.0 5,113.10 Acute Myocardial Infarction 17,687.46 2.6 6,802.87 Alcohol Abuse & Dependence 19,126.64 4.2 4,553.96 Alcoholic

More information

Physical Therapy Diagnosis and Documentation Tips

Physical Therapy Diagnosis and Documentation Tips 1 This tool is designed to assist the Physical Therapist in consultation with the physician, in the selection of an appropriate according to Medicare coverage guidelines. The documentation tips will add

More information

Changes for Physician Measurement 2018

Changes for Physician Measurement 2018 Changes for Physician Measurement 2018 Measure Name Guidelines for Physician Measurement Effectiveness of Care Changes Revised the Systematic Sampling Methodology to require organizations to report using

More information

Medical Mental Health Reference Data. Florida Safe Families Network FSFN. May 12, 2017 Page 1 FSFN. Medical Mental Health. Page: Tab Name: Field Name:

Medical Mental Health Reference Data. Florida Safe Families Network FSFN. May 12, 2017 Page 1 FSFN. Medical Mental Health. Page: Tab Name: Field Name: Mental Health Profile Alcohol, Drugs, Marijuana, Solvents Frequency Daily Isolated Known Use / Unknown Frequency Occasional/Monthly Use Weekly Medical History Condition Type Dental Medical Mental Medical

More information

California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar

California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar Production Automation and Quality Control Unit Data Alert - Registrar 2015-063 REVISED - Clarification Casefinding List for FY2016 Updated Please see additional codes inadvertently excluded from the previous

More information

Errata. Basic ICD-9-CM Coding, 2006 Edition AC200505K

Errata. Basic ICD-9-CM Coding, 2006 Edition AC200505K Errata Basic ICD-9-CM Coding, 2006 Edition AC200505K Last minute updates in the coding of percutaneous transluminal coronary angioplasty (chapter 10 of book) and encounters for chemotherapy (chapter 23

More information

TABLE 3: CY 2019 CASE-MIX ADJUSTMENT VARIABLES AND SCORES

TABLE 3: CY 2019 CASE-MIX ADJUSTMENT VARIABLES AND SCORES TABLE 3: CY 2019 CASE-MIX ADJUSTMENT VARIABLES SCORES Episode number within sequence of adjacent episodes 1 or 2 1 or 2 3+ 3+ Therapy 0-13 14+ 0-13 14+ EQUATION: 1 2 3 4 CLINICAL DIMENSION 1 Primary or

More information

CARE CONSIDERATIONS FOR DUCHENNE MUSCULAR DYSTROPHY

CARE CONSIDERATIONS FOR DUCHENNE MUSCULAR DYSTROPHY IMPORTANT NEW UPDATE A Summary of the Report of the DMD Care Considerations Working Group Intended for US healthcare professionals only. CARE CONSIDERATIONS FOR DUCHENNE MUSCULAR DYSTROPHY Full article

More information

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5). Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.

More information

CODING GUIDELINES CODING GUIDELINES - ICD CODING GUIDELINES - OPCS4...5 GENERAL INFORMATION...6 DQA NEWS...7. No.

CODING GUIDELINES CODING GUIDELINES - ICD CODING GUIDELINES - OPCS4...5 GENERAL INFORMATION...6 DQA NEWS...7. No. CODING GUIDELINES No. 17 January, 2006 Please note that the Coding Advisory Service Telephone Number is 0131-275-7283. The number is manned Tuesday to Thursday from 09.00 to 17.00 hrs. The link for previous

More information

ANATOMY 2 LEARNING TARGETS

ANATOMY 2 LEARNING TARGETS ANATOMY 2 LEARNING TARGETS NERVOUS SYSTEM 1. Distinguish between the parts of the central nervous system and the peripheral nervous system. 2. Identify the neuron as the basic structural and functional

More information

ICD 10 CM Coding and Documentation

ICD 10 CM Coding and Documentation ICD 10 CM Coding and Documentation Adult Day Health Care Council Karen L. Fabrizio, RHIA, CHTS CP, CPRA April 10, 2014 Presented by: Karen Fabrizio, RHIA CHTS CP CPRA is an AHIMA Approved ICD 10 CM/PCS

More information

Highlights of the NEW 2017 Codes ICD-10- CM

Highlights of the NEW 2017 Codes ICD-10- CM Highlights of the NEW 2017 Codes ICD-10- CM Maine HIMA September 22, 2016 ICD-10-CM o 1943 New Codes o 422 Revised Codes o 305 Deleted Codes Overall Picture o Which revisions apply most to your facility?

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Keytruda (pembrolizumab) MP-014-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date: 01/15/2018; 08/01/2017; 06/01/2016

More information